# Sleepiness and the Effects of CPAP on Salivary Cortisol and Alpha-Amylase Levels in Patients With Sleep Apnea

> **NCT01196117** · NA · COMPLETED · sponsor: **Medical College of Wisconsin** · enrollment: 18 (actual)

## Conditions studied

- Sleep Apnea
- Sleep Disordered Breathing

## Interventions

- **DEVICE:** 14 days of placebo therapy
- **DEVICE:** 14 days of CPAP therapy

## Key facts

- **NCT ID:** NCT01196117
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11-15
- **Primary completion:** 2011-12-15
- **Final completion:** 2011-12-15
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01196117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01196117, "Sleepiness and the Effects of CPAP on Salivary Cortisol and Alpha-Amylase Levels in Patients With Sleep Apnea". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01196117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
